David Webb

A prospective study of switching asthma patients from a Fixed-Dose Combination (FDC) Inhaled Corticosteroid [ICS]/Long-Acting Beta Agonist [LABA] therapy delivered by Dry Powder Inhaler (DPI) to ICS/LABA delivered by pressurised Metered Dose Inhaler (pMDI).

M. Al-Ahmad, David Webb, M. Al‐Ahmad, 2022, Respiratory medicine.

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

P. Gosse, S. Oparil, Pankaj Gupta, 2022, The Lancet.

Switching to Prolonged Release Oxycodone/Naloxone Fixed Combination Improves Pain Control Without Affecting Bowel Function in Patients with Moderate to Severe Cancer Pain: A retrospective, observational, real-world study

Iman AlDiri, Ibrahim Eskarose, David Webb, 2021, Journal of Community Medicine and Public Health Reports.

Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect

Rachael Williams, T. V. van Staa, M. Sperrin, 2018, BMJ Open Respiratory Research.

Chronic obstructive pulmonary disease exacerbation episodes derived from electronic health record data validated using clinical trial data

M. Sperrin, K. Davis, J. Pimenta, 2019, Pharmacoepidemiology and drug safety.